"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer

Oncology Times Broadcast News

Sep 28, 200900:02:18Science & Medicine

BARCELONA, SPAIN—Adding cetuximab to gemcitabine/oxaliplatin (GEMOX) chemotherapy controlled disease among two thirds of patients with advanced biliary cancer in a trial reported at the World Congress on Gastrointestinal...

Related Episodes

Continue listening to more episodes from Oncology Times Broadcast News.

Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality

Oct 6, 2009 - 00:04:20

Oncology Times Broadcast News Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased...

Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue!

Oct 6, 2009 - 00:06:57

Oncology Times Broadcast News Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for...

Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

Sep 28, 2009 - 00:07:19

John Burn talking at ECCO15-ESMO34 in Berlin about his international study showing that aspirin prevented...

For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends Survival

Sep 28, 2009 - 00:06:03

Oncology Times Broadcast News For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Exte...

Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer

Sep 28, 2009 - 00:09:05

Oncology Times Broadcast News: Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For...

Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos

Sep 28, 2009 - 00:06:23

Oncology Times Broadcast News: Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinoteca...

Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival

Sep 28, 2009 - 00:04:37

Oncology Times Broadcast News: Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Pro...

Colorectal Cancer: KRAS-Driven Selection Of Molecular Therapy Could Save Millions: Bevacizumab, Cetuximab, Panitumomab, or Combinations?

Sep 28, 2009 - 00:03:39

11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews Joh...